Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
七味放化颗粒对鼻咽癌放疗减毒作用的随机、双盲、安慰剂平行对照、多中心2期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial of Qiwei Fanghua Granules for reducing toxicity of nasopharyngeal carcinoma during radiotherapy
探索七味放化颗粒辅助用药对鼻咽癌放疗减毒作用的有效性和安全性
[Translation] To explore the effectiveness and safety of Qiwei Fanghua Granules as an adjuvant drug for the detoxification of nasopharyngeal carcinoma by radiotherapy
七味放化颗粒对非小细胞肺癌化疗减毒作用的随机、双盲、安慰剂平行对照、多中心2期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial of Qiwei Fanghua Granules for reducing chemotherapy toxicity in non-small cell lung cancer
探索七味放化颗粒辅助用药对非小细胞肺癌化疗的有效性和安全性
[Translation] To explore the effectiveness and safety of Qiwei Fanghua Granule as an adjuvant drug for chemotherapy of non-small cell lung cancer
100 Clinical Results associated with Guangdong Sanjie Trading Co., Ltd.
0 Patents (Medical) associated with Guangdong Sanjie Trading Co., Ltd.
100 Deals associated with Guangdong Sanjie Trading Co., Ltd.
100 Translational Medicine associated with Guangdong Sanjie Trading Co., Ltd.